Per Odin
51 – 60 of 178
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries
Malaty, Irene A. ; Martinez-Martin, Pablo ; Chaudhuri, K. Ray ; Odin, Per LU
; Skorvanek, Matej
; Jimenez-Shahed, Joohi
; Soileau, Michael J.
; Lindvall, Susanna
; Domingos, Josefa
and Jones, Sarah
, et al.
(2022)
In BMC Neurology
22(1).
- Contribution to journal › Article
-
Mark
Diagnostic work up : Laboratory and biomarkers
Cedergren Weber, Gustav and Odin, Per LU
(2022)
In International Review of Neurobiology
162.
p.53-96
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Safinamide in the treatment pathway of Parkinson’s Disease : a European Delphi Consensus
Stocchi, Fabrizio ; Antonini, Angelo ; Berg, Daniela ; Bergmans, Bruno ; Jost, Wolfgang ; Katzenschlager, Regina ; Kulisevsky, Jaime ; Odin, Per LU
; Valldeoriola, Francesc
and Ray Chaudhuri, K.
(2022)
In npj Parkinson's Disease
8.
- Contribution to journal › Article
-
Mark
Quality of life and resource utilization-Swedish data from the Care of Late-Stage Parkinsonism (CLaSP) study
M. Norlin, Jenny ; Hjalte, Frida ; Kruse, Christopher ; Dodel, Richard ; Rosqvist, Kristina LU and Odin, Per LU
(2022)
In Acta Neurologica Scandinavica
145(6).
p.743-752
- Contribution to journal › Article
-
Mark
Objective Observer vs. Patient Motor State Assessments Using the PD Home Diary in Advanced Parkinson's Disease
Timpka, Jonathan LU ; Löhle, Matthias ; Bremer, Alexander ; Christiansson, Sofia ; Gandor, Florin ; Ebersbach, Georg ; Dahlström, Örjan ; Iwarsson, Susanne LU ; Nilsson, Maria H LU
and Storch, Alexander
, et al.
(2022)
In Frontiers in Neurology
13.
- Contribution to journal › Article
-
Mark
Insights on Genetic and Environmental Factors in Parkinson's Disease from a Regional Swedish Case-Control Cohort
Brolin, Kajsa LU
; Bandres-Ciga, Sara
; Blauwendraat, Cornelis
; Widner, Håkan
LU
; Odin, Per
LU
; Hansson, Oskar
LU
; Puschmann, Andreas
LU
and Swanberg, Maria
LU
(2022)
In Journal of Parkinson's Disease
12(1).
p.153-171
- Contribution to journal › Article
-
Mark
Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
Bergquist, Filip ; Ehrnebo, Mats ; Nyholm, Dag ; Johansson, Anders ; Lundin, Fredrik ; Odin, Per LU
; Svenningsson, Per
; Hansson, Fredrik
; Bring, Leif
and Eriksson, Elias
, et al.
(2022)
In Neurology
99(10).
p.965-976
- Contribution to journal › Article
-
Mark
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson’s Disease : A Systematic Review and Bayesian Network Meta-analysis
Antonini, Angelo ; Pahwa, Rajesh ; Odin, Per LU
; Isaacson, Stuart H.
; Merola, Aristide
; Wang, Lin
; Kandukuri, Prasanna L.
; Alobaidi, Ali
; Yan, Connie H.
and Bao, Yanjun
, et al.
(2022)
In CNS Drugs
36(12).
p.1269-1283
- Contribution to journal › Scientific review
-
Mark
Impact of age at onset on symptom profiles, treatment characteristics and health-related quality of life in Parkinson’s disease
Raket, Lars Lau LU
; Oudin Åström, Daniel
LU
; Norlin, Jenny M.
; Kellerborg, Klas
; Martinez-Martin, Pablo
and Odin, Per
LU
(2022)
In Scientific Reports
12(1).
- Contribution to journal › Article
-
Mark
Effects of Levodopa-Carbidopa Intestinal Gel on Dyskinesia and Non-Motor Symptoms Including Sleep : Results from a Meta-Analysis with 24-Month Follow-Up
Chaudhuri, K. Ray ; Antonini, Angelo ; Pahwa, Rajesh ; Odin, Per LU
; Titova, Nataliya
; Thakkar, Sandeep
; Snedecor, Sonya J.
; Hegde, Saket
; Alobaidi, Ali
and Parra, Juan Carlos
, et al.
(2022)
In Journal of Parkinson's Disease
12(7).
p.2071-2083
- Contribution to journal › Scientific review